Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Vauquelin

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
European Journal of Pharmacology|June 5, 1986
Molecular distinction between calf heart and brain muscarine receptors: different N-ethylmaleimide modulation of agonist bindingP Vanderheyden, L Kanarek, G Vauquelin
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1986
Agonist-mediated conformational changes of beta-adrenoceptors could occur independent of functional coupling to NsY Severne, L Kanarek, G Vauquelin
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1990
Dual effect of N-ethylmaleimide on agonist binding to bovine heart muscarinic receptorsG Vauquelin, P Vanderheyden, G Ebinger
Vision Research|January 1, 1988
Characterization of M1- and M2-muscarinic receptors in calf retina membranesP Vanderheyden, G Ebinger, G Vauquelin
Molecular Pharmacology|April 1, 1988
Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicityI Debing, A P Ijzerman, G Vauquelin
Neuroscience Letters|October 9, 1989
Evidence for a widespread dopaminergic innervation of the human cerebral neocortexJ De Keyser, G Ebinger, G Vauquelin
Annals of Neurology|February 1, 1990
Age-related changes in the human nigrostriatal dopaminergic systemJ De Keyser, G Ebinger, G Vauquelin
Archives of Neurology|July 1, 1990
D1-dopamine receptor abnormality in frontal cortex points to a functional alteration of cortical cell membranes in Alzheimer's diseaseJ De Keyser, G Ebinger, G Vauquelin
British Journal of Pharmacology|July 15, 2009
Molecular mechanisms for the persistent bronchodilatory effect of the beta 2-adrenoceptor agonist salmeterolA Szczuka, M Wennerberg, A Packeu, et al.
British Journal of Pharmacology|October 16, 2010
Estimation of the dissociation rate of unlabelled ligand-receptor complexes by a 'two-step' competition binding approachA Packeu, M Wennerberg, A Balendran, et al.
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
European Journal of Pharmacology|June 5, 1986
Molecular distinction between calf heart and brain muscarine receptors: different N-ethylmaleimide modulation of agonist bindingP Vanderheyden, L Kanarek, G Vauquelin
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1986
Agonist-mediated conformational changes of beta-adrenoceptors could occur independent of functional coupling to NsY Severne, L Kanarek, G Vauquelin
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1990
Dual effect of N-ethylmaleimide on agonist binding to bovine heart muscarinic receptorsG Vauquelin, P Vanderheyden, G Ebinger
Vision Research|January 1, 1988
Characterization of M1- and M2-muscarinic receptors in calf retina membranesP Vanderheyden, G Ebinger, G Vauquelin
Molecular Pharmacology|April 1, 1988
Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicityI Debing, A P Ijzerman, G Vauquelin
Neuroscience Letters|October 9, 1989
Evidence for a widespread dopaminergic innervation of the human cerebral neocortexJ De Keyser, G Ebinger, G Vauquelin
Annals of Neurology|February 1, 1990
Age-related changes in the human nigrostriatal dopaminergic systemJ De Keyser, G Ebinger, G Vauquelin
Archives of Neurology|July 1, 1990
D1-dopamine receptor abnormality in frontal cortex points to a functional alteration of cortical cell membranes in Alzheimer's diseaseJ De Keyser, G Ebinger, G Vauquelin
British Journal of Pharmacology|July 15, 2009
Molecular mechanisms for the persistent bronchodilatory effect of the beta 2-adrenoceptor agonist salmeterolA Szczuka, M Wennerberg, A Packeu, et al.
British Journal of Pharmacology|October 16, 2010
Estimation of the dissociation rate of unlabelled ligand-receptor complexes by a 'two-step' competition binding approachA Packeu, M Wennerberg, A Balendran, et al.
Pageof 14